Clinical trial
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
NCT04191031 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 30, 2020
- Completion date
- July 12, 2022
- Enrollment
- 79 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
post-operative pain management